PlainPharmaWatch

CMS Open Payments · Program Year 2024

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC reported $1,520,356.63 across General Payments, Research, and Ownership to 8,126 physicians and teaching hospitals across 8,141 transactions.

See the rankings → How this is sourced
$1.5M
All-tracks total
8,141
Transactions
8,126
Recipients
−$67.1K
General Payments vs PY2023

Fresenius Kabi USA, LLC reported $1,520,356.63 across all CMS Open Payments tracks (General + Research + Ownership) to 8,126 physicians and teaching hospitals in Program Year 2024 - ranking #522 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,305,587.14, averaging $187.10 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer fresenius-kabi-usa-llc Fresenius Kabi USA, LLC

$1.5M · #522/1,925 · 0.0% industry · PY2024

  • TOT $1.5M
  • RANK #522
  • SHARE 0.0%
  • TXN 8,141
  • RCP 8,126
  • CAT 6
  • GEN $1.3M
  • ΔGEN −$67.1K
  • TOP1 59.3%
  • PY 2024

Volume peers

Nearest volume peer: ExThera Medical Corporation ($1.5M)

Balt USA, LLC$1.5MCollegium Pharmaceutical, In…$1.5MInvivyd Inc$1.5MExThera Medical Corporation$1.5MFresenius Kabi USA, LLC (thi…$1.5M
All-tracks payment totals near Fresenius Kabi USA, LLC (CMS Open Payments PY2024)

Fresenius Kabi USA, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Fresenius Kabi USA, LLC's CMS-reported General Payments decreased by $67.1K (−4.9%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: FRESENIUS KABI USA, LLCPY2023: FRESENIUS KABI USA, LLCPY2024: Fresenius Kabi USA, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.4MPY2024$1.3M
PY2023
$1,372,731.05
PY2024
$1,305,587.14

What the Data Shows for Fresenius Kabi USA, LLC

In Program Year 2024, Fresenius Kabi USA, LLC reported $1,520,356.63 in payments to 8,126 physicians and teaching hospitals across 8,141 individual transactions, an average of $186.75 per transaction and $187.10 per recipient. That total places Fresenius Kabi USA, LLC at rank #522 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Royalty or License" leads the 6-category general-payment breakdown below at $774.7K (59.3% of General Payments, 4 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Fresenius Kabi USA, LLC made 6 types of general payments. "Royalty or License" is the largest category at $774.7K, 59.3% of General Payments.

Fresenius Kabi USA, LLC reports 6 general-payment categories - the top three are Royalty or License (59.3%), Food and Beverage (14.4%), and Consulting Fee (10.6%). The remaining 3 categories make up 15.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Fresenius Kabi USA, LLC divides its payments

Ranked by total dollars reported per category

1. Royalty or License$774.7K2. Food and Beverage$187.4K3. Consulting Fee$138.7K4. Compensation for Services…$112.7K5. Space Rental or Facility …$48.8K6. Travel and Lodging$43.3K
Payment Type Amount Transactions
Royalty or License $774.7K 4
Food and Beverage $187.4K 7,859
Consulting Fee $138.7K 58
Compensation for Services Other Than Consulting $112.7K 35
Space Rental or Facility Fees $48.8K 15
Travel and Lodging $43.3K 155

Recipient Concentration in General Payments

The five largest recipient relationships account for $891,960.54 (68.3%) of $1,305,587.14 in this company's General Payments records across 4,103 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Fresenius Kabi USA, LLC

The five named recipients with the highest reported General Payments from this company

Childrens Hospital Corporati…$774.7KDavid C Evans$42.1KMichael John Fitzgerald$38.2KRobert G Martindale$19.4KJeffery S Vender$17.6K
  1. 1

    Childrens Hospital Corporation

    $774,722.04 across 4 reported transactions

  2. 2

    David C Evans

    $42,058.48 across 80 reported transactions

  3. 3

    Michael John Fitzgerald

    $38,213.62 across 67 reported transactions

  4. 4

    Robert G Martindale

    $19,386.88 across 10 reported transactions

  5. 5

    Jeffery S Vender

    $17,579.52 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Fresenius Kabi USA, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Fresenius Kabi USA, LLC.

CMF Medicon Surgical Inc.

HHI 3560

Therakos Healthcare LLC

HHI 3564

Natus Medical Incorporated

HHI 3565

Immunocore Limited

HHI 3543

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Fresenius Kabi USA, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Fresenius Kabi USA, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.